| Quantifying individual variation in the propensity to attribute incentive salience to reward cues PJ Meyer, V Lovic, BT Saunders, LM Yager, SB Flagel, JD Morrow, ... PloS one 7 (6), e38987, 2012 | 324 | 2012 |
| Variation in the form of Pavlovian conditioned approach behavior among outbred male Sprague-Dawley rats from different vendors and colonies: sign-tracking vs. goal-tracking CJ Fitzpatrick, S Gopalakrishnan, ES Cogan, LM Yager, PJ Meyer, ... PloS one 8 (10), e75042, 2013 | 138 | 2013 |
| Interleukin-6 alters sleep of rats D Hogan, JD Morrow, EM Smith, MR Opp Journal of neuroimmunology 137 (1-2), 59-66, 2003 | 124 | 2003 |
| Sleep–wake behavior and responses of interleukin-6-deficient mice to sleep deprivation JD Morrow, MR Opp Brain, behavior, and immunity 19 (1), 28-39, 2005 | 96 | 2005 |
| Individual variation in the propensity to attribute incentive salience to an appetitive cue predicts the propensity to attribute motivational salience to an aversive cue JD Morrow, S Maren, TE Robinson Behavioural brain research 220 (1), 238-243, 2011 | 94 | 2011 |
| Rats that sign-track are resistant to Pavlovian but not instrumental extinction AM Ahrens, BF Singer, CJ Fitzpatrick, JD Morrow, TE Robinson Behavioural brain research 296, 418-430, 2016 | 91 | 2016 |
| Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice JD Morrow, MR Opp Brain, behavior, and immunity 19 (1), 40-51, 2005 | 84 | 2005 |
| Mechanisms of shared vulnerability to post-traumatic stress disorder and substance use disorders CE María-Ríos, JD Morrow Frontiers in Behavioral Neuroscience 14, 6, 2020 | 57 | 2020 |
| Sign-tracking to an appetitive cue predicts incubation of conditioned fear in rats JD Morrow, BT Saunders, S Maren, TE Robinson Behavioural brain research 276, 59-66, 2015 | 50 | 2015 |
| Effects of serotonergic activation by 5-hydroxytryptophan on sleep and body temperature of C57BL/6J and interleukin-6-deficient mice are dose and time related JD Morrow, S Vikraman, L Imeri, MR Opp Sleep 31 (1), 21-33, 2008 | 41 | 2008 |
| Neuroscience of resilience and vulnerability for addiction medicine: From genes to behavior JD Morrow, SB Flagel Progress in brain research 223, 3-18, 2016 | 36 | 2016 |
| Sign-tracking, response inhibition, and drug-induced vocalizations PJ Meyer, JA Tripi, A Tomie, J Morrow Sign-tracking and drug addiction, 2018 | 30 | 2018 |
| Neurobiology of adolescent substance use disorders A Sharma, JD Morrow Child and Adolescent Psychiatric Clinics 25 (3), 367-375, 2016 | 29 | 2016 |
| Pavlovian conditioned approach training in rats CJ Fitzpatrick, JD Morrow JoVE (Journal of Visualized Experiments), e53580, 2016 | 29 | 2016 |
| Genetic characterization of outbred Sprague Dawley rats and utility for genome-wide association studies AF Gileta, CJ Fitzpatrick, AS Chitre, CL St. Pierre, EV Joyce, RJ Maguire, ... PLoS Genetics 18 (5), e1010234, 2022 | 28 | 2022 |
| Lesions of the ventral hippocampus attenuate the acquisition but not expression of sign‐tracking behavior in rats CJ Fitzpatrick, JF Creeden, SA Perrine, JD Morrow Hippocampus 26 (11), 1424-1434, 2016 | 26 | 2016 |
| Sign-tracking behavior is difficult to extinguish and resistant to multiple cognitive enhancers CJ Fitzpatrick, T Geary, JF Creeden, JD Morrow Neurobiology of learning and memory 163, 107045, 2019 | 25 | 2019 |
| Exermania J Morrow, P Harvey American Health 9 (9), 31-32, 1990 | 22 | 1990 |
| Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues CJ Fitzpatrick, JD Morrow Journal of Psychopharmacology 31 (1), 67-74, 2017 | 21 | 2017 |
| Reconsidering the usefulness of adding naloxone to buprenorphine CK Blazes, JD Morrow Frontiers in Psychiatry, 958, 2020 | 20 | 2020 |
